Replies to post #297707 on Avid Bioservices Inc (CDMO)

[jakedogman1]

agree to some extent... the abstract was for 18 patients for safety so were those patients tested before enrollment... would need to look at timeline..

another mystery.. yet to be solved..

[InternetForumUser]

Agree about not retracting that ABSTRACT but they also should have made a statement in regards to it because it is even being used as a reference in published articles. There was one recently where it was using it as the primary reference.

So is it normal to draft and submit abstracts for a Trial that never even started? Not only is it premature, it seems shady and dishonest. Guess the buck stops with PPHM Management and BOD

[asmarterwookie]

I emailed Stephanie Diaz on this topic but never received a response.

The Durvalumab / Bavituximab study cited in that paper NEVER got started. Since this is the 3rd time this link has been put up on this message board in the last one month or so, it is important to note that the study was withdrawn PRIOR to enrollment

https://clinicaltrials.gov/ct2/show/NCT02673814?term=bavituximab&rank=17

Shame on $PPHM for not withdrawing that abstract. Now it gets cited in papers and this myth keeps perpetuating.

Preposterous.

wook